-
Je něco špatně v tomto záznamu ?
Autosomal dominant tubulointerstitial kidney disease
O. Devuyst, E. Olinger, S. Weber, KU. Eckardt, S. Kmoch, L. Rampoldi, AJ. Bleyer,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
NV17-29786A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
ProQuest Central
od 2015-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2015-01-01 do Před 1 rokem
- MeSH
- biopsie metody MeSH
- chronické selhání ledvin epidemiologie etiologie MeSH
- genetické nemoci vrozené komplikace epidemiologie MeSH
- lidé MeSH
- polycystické ledviny autozomálně dominantní komplikace epidemiologie patofyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney diseases characterized by tubular damage and interstitial fibrosis in the absence of glomerular lesions, with inescapable progression to end-stage renal disease. These diseases have long been neglected and under-recognized, in part due to confusing and inconsistent terminology. The introduction of a gene-based, unifying terminology led to the identification of an increasing number of cases, with recent data suggesting that ADTKD is one of the more common monogenic kidney diseases after autosomal dominant polycystic kidney disease, accounting for ~5% of monogenic disorders causing chronic kidney disease. ADTKD is caused by mutations in at least five different genes, including UMOD, MUC1, REN, HNF1B and, more rarely, SEC61A1. These genes encode various proteins with renal and extra-renal functions. The mundane clinical characteristics and lack of appreciation of family history often result in a failure to diagnose ADTKD. This Primer highlights the different types of ADTKD and discusses the distinct genetic and clinical features as well as the underlying mechanisms.
Division of Genetics and Cell Biology IRCCS San Raffaele Scientific Institute Milan Italy
Section on Nephrology Wake Forest School of Medicine Winston Salem NC USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025664
- 003
- CZ-PrNML
- 005
- 20201222154026.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41572-019-0109-9 $2 doi
- 035 __
- $a (PubMed)31488840
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Devuyst, Olivier $u Institute of Physiology, Mechanisms of Inherited Kidney Disorders Group, University of Zurich, Zurich, Switzerland. olivier.devuyst@uzh.ch. Division of Nephrology, UCLouvain Medical School, Brussels, Belgium. olivier.devuyst@uzh.ch.
- 245 10
- $a Autosomal dominant tubulointerstitial kidney disease / $c O. Devuyst, E. Olinger, S. Weber, KU. Eckardt, S. Kmoch, L. Rampoldi, AJ. Bleyer,
- 520 9_
- $a Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney diseases characterized by tubular damage and interstitial fibrosis in the absence of glomerular lesions, with inescapable progression to end-stage renal disease. These diseases have long been neglected and under-recognized, in part due to confusing and inconsistent terminology. The introduction of a gene-based, unifying terminology led to the identification of an increasing number of cases, with recent data suggesting that ADTKD is one of the more common monogenic kidney diseases after autosomal dominant polycystic kidney disease, accounting for ~5% of monogenic disorders causing chronic kidney disease. ADTKD is caused by mutations in at least five different genes, including UMOD, MUC1, REN, HNF1B and, more rarely, SEC61A1. These genes encode various proteins with renal and extra-renal functions. The mundane clinical characteristics and lack of appreciation of family history often result in a failure to diagnose ADTKD. This Primer highlights the different types of ADTKD and discusses the distinct genetic and clinical features as well as the underlying mechanisms.
- 650 _2
- $a biopsie $x metody $7 D001706
- 650 _2
- $a genetické nemoci vrozené $x komplikace $x epidemiologie $7 D030342
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronické selhání ledvin $x epidemiologie $x etiologie $7 D007676
- 650 _2
- $a polycystické ledviny autozomálně dominantní $x komplikace $x epidemiologie $x patofyziologie $7 D016891
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Olinger, Eric $u Institute of Physiology, Mechanisms of Inherited Kidney Disorders Group, University of Zurich, Zurich, Switzerland.
- 700 1_
- $a Weber, Stefanie $u Division of Pediatric Nephrology and Transplantation, University Children's Hospital Marburg, Marburg, Germany.
- 700 1_
- $a Eckardt, Kai-Uwe $u Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Rampoldi, Luca $u Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- 700 1_
- $a Bleyer, Anthony J $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
- 773 0_
- $w MED00200655 $t Nature reviews. Disease primers $x 2056-676X $g Roč. 5, č. 1 (2019), s. 60
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31488840 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222154022 $b ABA008
- 999 __
- $a ok $b bmc $g 1599809 $s 1116350
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 5 $c 1 $d 60 $e 20190905 $i 2056-676X $m Nature reviews. Disease primers $n Nat Rev Dis Primers $x MED00200655
- GRA __
- $a NV17-29786A $p MZ0
- LZP __
- $a Pubmed-20201125